Our partner is dedicated to developing innovative therapies for autoimmune and rare diseases. They focus on creating targeted treatments that address the underlying causes of these conditions, aiming to improve patient outcomes and quality of life through precision medicine.

This critical hire reported directly to the Chief Medical Officer. They were responsible for providing strategic and scientific leadership and oversight for all Drug Safety/ Pharmacovigilance and Risk Management activities to ensure proactive and timely benefit-risk assessments of all safety data throughout the lifecycle of our partner's assets from clinical development through post marketing.